Gastric cancer: Current status of diagnosis and treatment

Tsunehiro Takahashi, Yoshiro Saikawa, Yuukou Kitagawa

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Gastric cancer is the second leading cause of death from malignant disease worldwide and most frequently discovered in advanced stages. Because curative surgery is regarded as the only option for cure, early detection of resectable gastric cancer is extremely important for good patient outcomes. Therefore, noninvasive diagnostic modalities such as evolutionary endoscopy and positron emission tomography are utilized as screening tools for gastric cancer. To date, early gastric cancer is being treated using minimally invasive methods such as endoscopic treatment and laparoscopic surgery, while in advanced cancer it is necessary to consider multimodality treatment including chemotherapy, radiotherapy, and surgery. Because of the results of large clinical trials, surgery with extended lymphadenectomy could not be recommended as a standard therapy for advanced gastric cancer. Recent clinical trials had shown survival benefits of adjuvant chemotherapy after curative resection compared with surgery alone. In addition, recent advances of molecular targeted agents would play an important role as one of the modalities for advanced gastric cancer. In this review, we summarize the current status of diagnostic technology and treatment for gastric cancer.

Original languageEnglish
Pages (from-to)48-63
Number of pages16
JournalCancers
Volume5
Issue number1
DOIs
Publication statusPublished - 2013 Mar

Fingerprint

Stomach Neoplasms
Therapeutics
Clinical Trials
Adjuvant Chemotherapy
Lymph Node Excision
Positron-Emission Tomography
Laparoscopy
Endoscopy
Cause of Death
Radiotherapy
Technology
Drug Therapy
Survival
Neoplasms

Keywords

  • Chemotherapy
  • Gastric cancer
  • Molecular targeted therapy
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Gastric cancer : Current status of diagnosis and treatment. / Takahashi, Tsunehiro; Saikawa, Yoshiro; Kitagawa, Yuukou.

In: Cancers, Vol. 5, No. 1, 03.2013, p. 48-63.

Research output: Contribution to journalArticle

Takahashi, Tsunehiro ; Saikawa, Yoshiro ; Kitagawa, Yuukou. / Gastric cancer : Current status of diagnosis and treatment. In: Cancers. 2013 ; Vol. 5, No. 1. pp. 48-63.
@article{8c93816be9bf43ecadde55b9139723c4,
title = "Gastric cancer: Current status of diagnosis and treatment",
abstract = "Gastric cancer is the second leading cause of death from malignant disease worldwide and most frequently discovered in advanced stages. Because curative surgery is regarded as the only option for cure, early detection of resectable gastric cancer is extremely important for good patient outcomes. Therefore, noninvasive diagnostic modalities such as evolutionary endoscopy and positron emission tomography are utilized as screening tools for gastric cancer. To date, early gastric cancer is being treated using minimally invasive methods such as endoscopic treatment and laparoscopic surgery, while in advanced cancer it is necessary to consider multimodality treatment including chemotherapy, radiotherapy, and surgery. Because of the results of large clinical trials, surgery with extended lymphadenectomy could not be recommended as a standard therapy for advanced gastric cancer. Recent clinical trials had shown survival benefits of adjuvant chemotherapy after curative resection compared with surgery alone. In addition, recent advances of molecular targeted agents would play an important role as one of the modalities for advanced gastric cancer. In this review, we summarize the current status of diagnostic technology and treatment for gastric cancer.",
keywords = "Chemotherapy, Gastric cancer, Molecular targeted therapy, Radiotherapy, Surgery",
author = "Tsunehiro Takahashi and Yoshiro Saikawa and Yuukou Kitagawa",
year = "2013",
month = "3",
doi = "10.3390/cancers5010048",
language = "English",
volume = "5",
pages = "48--63",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - Gastric cancer

T2 - Current status of diagnosis and treatment

AU - Takahashi, Tsunehiro

AU - Saikawa, Yoshiro

AU - Kitagawa, Yuukou

PY - 2013/3

Y1 - 2013/3

N2 - Gastric cancer is the second leading cause of death from malignant disease worldwide and most frequently discovered in advanced stages. Because curative surgery is regarded as the only option for cure, early detection of resectable gastric cancer is extremely important for good patient outcomes. Therefore, noninvasive diagnostic modalities such as evolutionary endoscopy and positron emission tomography are utilized as screening tools for gastric cancer. To date, early gastric cancer is being treated using minimally invasive methods such as endoscopic treatment and laparoscopic surgery, while in advanced cancer it is necessary to consider multimodality treatment including chemotherapy, radiotherapy, and surgery. Because of the results of large clinical trials, surgery with extended lymphadenectomy could not be recommended as a standard therapy for advanced gastric cancer. Recent clinical trials had shown survival benefits of adjuvant chemotherapy after curative resection compared with surgery alone. In addition, recent advances of molecular targeted agents would play an important role as one of the modalities for advanced gastric cancer. In this review, we summarize the current status of diagnostic technology and treatment for gastric cancer.

AB - Gastric cancer is the second leading cause of death from malignant disease worldwide and most frequently discovered in advanced stages. Because curative surgery is regarded as the only option for cure, early detection of resectable gastric cancer is extremely important for good patient outcomes. Therefore, noninvasive diagnostic modalities such as evolutionary endoscopy and positron emission tomography are utilized as screening tools for gastric cancer. To date, early gastric cancer is being treated using minimally invasive methods such as endoscopic treatment and laparoscopic surgery, while in advanced cancer it is necessary to consider multimodality treatment including chemotherapy, radiotherapy, and surgery. Because of the results of large clinical trials, surgery with extended lymphadenectomy could not be recommended as a standard therapy for advanced gastric cancer. Recent clinical trials had shown survival benefits of adjuvant chemotherapy after curative resection compared with surgery alone. In addition, recent advances of molecular targeted agents would play an important role as one of the modalities for advanced gastric cancer. In this review, we summarize the current status of diagnostic technology and treatment for gastric cancer.

KW - Chemotherapy

KW - Gastric cancer

KW - Molecular targeted therapy

KW - Radiotherapy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84875246405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875246405&partnerID=8YFLogxK

U2 - 10.3390/cancers5010048

DO - 10.3390/cancers5010048

M3 - Article

C2 - 24216698

AN - SCOPUS:84875246405

VL - 5

SP - 48

EP - 63

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 1

ER -